Article ID Journal Published Year Pages File Type
1324276 Journal of Organometallic Chemistry 2014 10 Pages PDF
Abstract

•The origins of bioorganometallic (medicinal) chemistry.•Properties of Ru(II)–arene complexes lend themselves pharmacological applications.•Rational target specific drug design.•Drug targeting strategies.•Beyond the ruthenium(II)–arene unit: Os, Rh and Ir and cyclopentadienyl systems.

Interest in the medicinal properties of ruthenium(II)–arene compounds has grown rapidly over the last decade. In this account we describe the origins of the field and subsequently highlight developments in the field, including the design of compounds that inhibit enzymes, the application of multinuclear systems to act as drug delivery vehicles, and the development of bioanalytical and biophysical methods to help elucidate the mechanisms by which these compounds function. The conducive properties and reasons for the rapid growth in interest in these and related compounds for their medicinal applications, especially in the treatment of solid tumours, are identified.

Graphical abstractThe medicinal properties of ruthenium(II)–arene compounds are attracting growing interest but how long will it be for one of these compounds to enter clinical trials?Figure optionsDownload full-size imageDownload as PowerPoint slide

Related Topics
Physical Sciences and Engineering Chemistry Inorganic Chemistry
Authors
, , ,